A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism

OBJECTIVE: The aim of this study was to investigate the role of pravastatin, as an adjunctive therapy, on inflammatory markers, lipid and glucose metabolism, psychopathology, and cognition in subjects with schizophrenia and schizoaffective disorder. METHODS: Schizophrenia or schizoaffective subjects...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Schizophr Res
Main Authors: Vincenzi, Brenda, Stock, Shannon, Borba, Christina P.C., Cleary, Sarah M., Oppenheim, Claire E., Petruzzi, Liana J., Fan, Xiaoduo, Copeland, Paul M., Freudenreich, Oliver, Cather, Corinne, Henderson, David C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4311769/
https://ncbi.nlm.nih.gov/pubmed/25261882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.schres.2014.08.021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados